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Abstract. The risk of mortality in breast cancer among women is a critical health issue 
worldwide. Scholars argue that breast cancer mortality rates have decreased in many 
advanced countries overall. However, about 50% of world population in 2017 was in poor 
and developing countries (more than 3,652 million with 50.24% female) and breast cancer 
mortality rates differ among nations also because of socioeconomic factors. This study 
investigates, at global level, breast cancer mortality in association with breast cancer 
incidence and some factors of socioeconomic ecosystem between poor and rich countries, to 
explain trends that can be used to gain insights into country-level “best practices” for health 
improvement. Global data regarding breast cancer incidence and mortality as the age 
standardized rate per 100,000 population in 78low-to-middle income countries (LMICs), 50 
upper-to-middle-income countries (UMICs) and 63 high income countries (HCIs) were 
obtained from IARC/WHO for 2012 and 2018. Data regarding GDP per capita, population 
and mammography (MMG) were obtained from World Bank, United Nations and WHO. 
Data, transformed in log scale to have normal distribution, were analyzed with descriptive 
statistics, partial correlation, regression analyses and paired-Samples T Test procedure to 
assess the statistical significance of increase or decrease of mortality and incidence in breast 
cancer from 2012 to 2018.Results reveal that a 1% higher level of breast cancer incidence, 
increases the expected mortality by 0.79% (p-value < .001) in LMICs, by 0.50% (p-value <.001) 
in UMICs and by 0.31% (p-value < .008) in HICs. These results, confirmed by other analyses 
here, seem to suggest that breast cancer mortality is increasing over time worldwide in rich 
and in particular developing countries. The global analysis here reveals that though an 
improvement of wealth and wellbeing worldwide, the risk of incidence and mortality in 
breast cancer is increasing. This result suggests that situational factors in the ecosystem of 
countries support the growing increase and mortality of breast cancer that improvement in 
healthcare and medicine of the last 40 years are not been sufficient to slowdown. These 
conclusions need for much more detailed research to investigate into the interaction 
between factors of socioeconomic systems, health improvement, and breast cancer causes.  
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1. Introduction 
bout 40 years ago, Myron Moskowitz argued “How Can We 
Decrease Breast Cancer Mortality?”, suggesting: “The data 
reviewed indicate that early detection is vital in decreasing breast 
cancer mortality. Early biopsy of minimally suspicious findings is 
important. Mortality can be reduced by perhaps 50 percent through 
 
aa† CNR, National research Council of Italy & Yale University School of Medicine, 310 Cedar 
Street, Lauder Hall, Suite 118, New Haven, CT 06520, USA. 
. + 85287-4804 . mario.coccia@cnr.it 
A 
Journal of Social and Administrative Sciences 
 M. Coccia, JSAS, 6(4), 2019, p.218-230. 
219 
219 
physical examination and mammography.” (Moskowitz, 1980, pp.276-277). 
However, although efforts in this direction of healthcare system in many 
counties, the risk of breast cancer mortality and incidence is still high in 
both rich and poor countries (Canto et al., 2001)1 . Hence, Moskowitz’s 
question in 1980 is still a current problem in2019.  
The purpose of this study is to analyze the risk of mortality in breast 
cancer, both in rich and poor countries, though a global analysis of this 
disease per nations to clarify comprehensive trends between countries and 
support appropriate health policies.  
 
2. Theoretical backround 
In medicine, cancer is an organism which lives off a host organ, growing 
by bio-genetic-molecular mechanism. In the world, 9.6 million people died 
of cancer in 2018 – more than from HIV, malaria and tuberculosis 
combined. The incidence of cancer is estimated to double by 2030s, with 
most of these cases expected to occur in low-to-middle income countries: in 
particular, 60% of cancer cases and 75% of cancer deaths occur in poor 
countries (cf., Prager et al., ‎2018). Table 1 shows that lung and breast cancer 
have the highest mortality rate worldwide (cf. also, Bray et al., 2018; Parkin 
et al., 2005).  
 
Table 1. Incidence and mortality of big 8 cancers in 2018 (worldwide data for both sexes, 
all ages) 
Cancer 
Incidence Mortality 
ASR (W)* ASR (W)* 
 Lung 22.5 18.6 
 Breast 46.3 13.0 
 Colorectum 19.7 8.9 
 Prostate 29.3 7.6 
 Stomach 11.1 8.2 
 Pancreas 4.8 4.4 
 Ovary 7.8 3.9 
 Liver 9.3 8.5 
Note: *Age-Standardized Rate-ASR (W): A rate is the number of new cases or deaths per 100,000 
persons per year. An age-standardized rate is the rate that a population would have if it had a standard 
age structure.  
Source. World Health Organization, International Agency for Research on Cancer (2019).  
 
The R&D in oncology is supporting the convergence of different 
research fields, such as genetics 2 , genomics 3 , nanotechnology, 
nanomedicine, computer sciences, etc., that are generating new 
 
1Abbreviations in the text: LMICs, low-to-middle income countries; UMICs, upper-to-middle 
income countries; HICs, high income countries; MPI, mortality-per-incident breast cancer 
ratio; MMG, mammography; GDP, Gross Domestic Product per capita.  
2 Genetics studies the molecular structure and function of genes in the context of a cell or 
organism. 
3 Genomics is a discipline in genetics that studies the genomes of organisms. In particular, it 
determines the entire DNA sequence of organisms and fine-scale genetic mapping efforts. 
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technological pathways for diagnostics and therapeutics (Coccia, 2014, 
2016; 2017, 2018, 2019, 2019a, 2019b; Coccia & Wang, 2015)4. 
Breast cancer is the most frequent cancer worldwide among women (see 
tab. 1; cf., Chagpar & Coccia, 2019). Studies based on advanced countries 
show that the incidence of breast cancer is increasing. Breast cancer 
incidence tends to be higher in more developed countries due to delayed 
childbearing, a higher use of hormone replacement therapy and oral 
contraceptives, a higher rate of screening, and improved tumor registries 
(Coccia, 2013). Some studies have also argued that higher income countries 
may generate a higher fat diets and an increased rate of obesity, both 
correlated with higher breast cancer incidence rates. In general, scholars 
note that many Western populations have a higher incidence rate of breast 
cancer than poor regions in Africa and Asia (Coccia, 2013; cf., Chagpar & 
Coccia, 2019; Engmann et al., 2017).  
 
3. Methods 
Sample 
Global data of this study are divided according to the classification by 
The World Bank (2018) to create homogenous groups for analysis, given by 
N1=78 low-to-middle income countries (LMICs), N2=50 upper-to-middle-
income countries (UMICs) and N3=63 high income countries (HCIs). These 
three groups are analyzed over a period from 2012 to 2018.   
Measures and sources of data 
Breast cancer incidence and mortality are measured in age standardized 
rate per 100,000 population and data were obtained from IARC/WHO 
(Globocan, 2018). Socioeconomic factors of nations under study here are 
Gross Domestic Product (GDP) per capita in 2015 year and Total 
Population 2017 using data obtained from The World Bank (2018). 
Screening for detection of breast cancer is measured with density of 
mammographs (per million females aged between 50 and 69 years old) 
using data of 2014 year from World Health Organization (2018).  
Data Analysis Procedure 
Data, in the presence of not normal distribution, are transformed in log 
scale. Our samples N1, N2and N3were analyzed with descriptive statistics, 
partial correlation (using as control variables density of mammographs 
2014 and GDP per capita 2015) and regression analyses. Some variables of 
the study here have a time lag to logically assess the effects on incidence 
and mortality in breast cancer. Linear regression is used to analyze the 
predicted value of the dependent variable of breast cancer mortality in 2018 
 
4 For other studies about drivers and effects of science and technology in society, see 
Cavallo et al., 2014; Coccia 2005, 2005a, 2005b, 2006, 2007, 2008, 2009, 2010, 2010a, 2011, 
2012, 2012a, 2012b, 2012c, 2013, 2014, 2014a, 2014b, 2014c, 2014d, 2014e, 2015, 2015a, 2015b, 
2015c, 2016, 2016a, 2016b, 2017, 2017a, 2017b, 2017c, 2017d, 2018, 2018a, 2018b, 2018c, 
2018d, 2018e, 2018f, 2018g, 2018h, 2018i, 2018l, 2018m, 2019, 2019a, 2019b, 2019c, 2019d; 
Coccia and Rolfo, 2002, 2009, 2013, Coccia & Wang, 2015, 2016.  
 
Journal of Social and Administrative Sciences 
 M. Coccia, JSAS, 6(4), 2019, p.218-230. 
221 
221 
on breast cancer incidence in 2012 (independent variable). The study also 
calculates from this model a new variable given by predicted values of 
breast cancer mortality in 2018 on breast cancer incidence in 2012 (the first 
stage). Then, in the second stage, using a linear regression model, it is 
estimated a new dependent variable on GDP per capita in 2015 to assess 
future trend in breast cancer. The analysis also calculates the burden of 
population with an increasing risk and decreasing risk of breast cancer 
considering the population in 2017. Finally, a paired-Samples t-Test 
compares two means of variables under study in 2012 and 2018 within the 
same group of nations LMICs, UMICs and HICs. The purpose of the test is 
to determine whether breast cancer incidence and mortality aresignificantly 
increased or decreased from 2012 to 2018.  
 
4. Results 
Table 1 shows that breast cancer incidence is higher in HICs than LMICs 
and UMICs both in 2012 and 2018. The average burden of mortality in 2012 
and 2018 also shows a higher level in rich countries than poor countries. 
However, temporal comparison of the groups of countries under study 
shows that from 2012 to 2018, breast cancer mortality is increased in LMICs 
and UMICs, whereas in HICs it has a moderate decline. Temporal variation 
of breast cancer incidence over 2012-2018 shows a general increase 
worldwide in each group of country under study. 
 
Table 1. Descriptive statistics 
Category 
Breast 
Cancer 
 Incidence 
2012 
Breast 
Cancer 
Incidence 
2018 
Breast 
Cancer 
Mortality 
2012 
Breast 
Cancer 
Mortality 
2018 
LMICs N Valid 73 71 73 71 
Missing 5 7 5 7 
Mean (M) 27.84 30.58 13.53 14.70 
Std. Deviation (SD) 10.67 11.84 5.16 5.81 
MUICs N Valid 44 45 44 45 
Missing 6 5 6 5 
Mean 42.00 46.08 14.30 15.35 
Std. Deviation 16.49 15.26 5.58 5.85 
HICs N Valid 54 53 54 53 
Missing 9 10 9 10 
Mean 68.36 71.87 15.18 14.89 
Std. Deviation 21.78 19.96 3.84 4.69 
 
The partial correlation of variables between breast cancer mortality 2018 
and breast cancer incidence 2012, controlling density of mammograms 
(2014) and GDP per capita (2015) shows a significant high association: 
LMICs (r=.75, p-value<.001), UMICs (r=.53, p-value<.004) and HICs (LMICs 
(r=.62, p-value<.001). 
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Table 2. Estimated relationships  
 
Unstandardized 
Coefficients 
Stand. 
Coefficients 
t Sig.    B Std. Error Beta F Sig. R2 adj 
LMICs Log Breast Cancer  
Incidence 2012 
.790 .084 .753 9.450 .001 89.298 .001 .561 
(Constant) .025 .275 
 
.089 .929 
   MUICs Log Breast Cancer  
Incidence 2012 
.497 .109 .577 4.577 .001 20.945 .001 .317 
(Constant) .841 .400 
 
2.104 .041 
   HICs Log Breast Cancer  
Incidence 2012 
.313 .113 .362 2.770 .008 7.672 .008 .288 
(Constant) 1.348 .474 
 
2.847 .006 
   Notes: The dependent variable is Log Breast Cancer Mortality 2018; Explanatory variable is Log Breast 
Cancer incidence 2012. 
 
Table 2 shows estimated relationships of breast cancer mortality in 2018 
on breast cancer incidence in 2012. In LMICs, results indicate that a 1% 
higher level of breast cancer incidence, increases the expected mortality by 
0.79% (p-value < .001, F=89.30, sig.=0.001, Adjusted R2=0.56). In UMICs, 
results indicate that a 1% higher level of breast cancer incidence, it 
increases the expected mortality by 0.50% (p-value <.001, F=20.95, sig. =0.001, 
Adjusted R2=0.32). Finally, in rich countries (HICs), results indicate that a 
1% higher level of breast cancer incidence, increases the expected mortality 
by 0.31% (p-value < .008, F=7.67, sig. =0.008, Adjusted R2=0.29). In general, 
statistical evidence here shows that the breast cancer mortality has an 
expected increase worldwide, though with different magnitude that is 
lower for rich countries, whereas it is higher for poor countries (cf., trends 
of regression lines are in Fig. 1).  
 
  
LMICs UMICs 
 
HICs 
Figure 1. Increasing trends of the risk of mortality in breast cancer across homogenous 
group of countries. 
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Moreover, paired samples test shows, from 2012 to 2018, the significant 
increase in LMICs of breast cancer mortality (t69=2.26,p-value<0.03) and 
breast cancer incidence (t69=2.64,p-value<0.01); in the same period, MUICs 
have an increase of mortality not significant, whereas the increase of breast 
cancer incidence is significant (t43=2.69,p-value<0.01). Finally, this test 
shows that in rich countries (HICs), breast cancer mortality from 2012 to 
2018 has a not significant decrease, whereas breast cancer incidence has a 
significant increase (t52=2.87,p-value<0.006). 
Empirical data also shows that countries reducing breast cancer 
mortality over 2012-2018 have 42.30% of worldwide population in 2017, 
whereas the countries increasing breast cancer mortality over 2012-2018 
represent 57.70% of worldwide population in 2017. Breast cancer incidence 
shows a higher difference over 2018-2012 between countries that are 
reducing incidence (about 40% of worldwide population) and countries 
that are increasing incidence (roughly 60% of worldwide population). 
Finally, the estimated relationship of predicted breast cancer mortality 
2018 with breast cancer incidence 2012 (from curve fit of model linear in log 
scale) on GDP per capita 2015 is significant only in rich countries. In 
particular, HICs show that a 1% higher level of GDP per capita, increases 
the expected breast cancer mortality (based on breast cancer incidence 
2012) by 0.1% (p-value <.001, F=17.80, sig.=0.001, Adjusted R2=0.25). These 
results seem to confirm that breast cancer mortality in rich countries can 
continue to increase also in the future (Figure2). 
  
 
Figure 2. Estimated relationship of expected increase of the risk of mortality in breast 
cancer on GDP per capita 
 
Figure 3 shows the spatial analysis of the variation of incidence across 
countries. Results reveal a general increase of breast cancer incidence from 
2012 to 2018, except in USA, Ecuador, Guyana, Libya, some countries in 
Central Africa, Saudi Arabia, India, Pakistan, Iraq, Uzbekistan and some 
other.  
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Figure 4 shows that the increase of breast cancer mortality is mainly in 
Mexico, some countries of Central America, Venezuela, Colombia, Bolivia, 
Paraguay, sub-Saharan Africa, India and China.  
 
 
Figure 3. Global map of the variation of breast cancer incidence over 2012-2018 in 
countries 
 
Figure 4. Global map of the variation of breast cancer mortality over 2012-2018 in 
countries 
 
 
5. Discussion and Conclusion 
DeSantis et al., (2017) and Mettlin (1999) argued that breast cancer 
mortality is declining in the United States and Canada, as well as in other 
advanced nations because of increasing screening (cf., Brentnall et al., 2018) 
and new therapies (cf., Bray et al., 2018). The global analysis here reveals 
that though an improvement of world-wide wellbeing, the risk of incidence 
and mortality in breast cancerseems to be increased. Countries with a 
problematic socioeconomic system (LMICs and UMICs) are at high risk 
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also because of demographic growth that in 2017 showed a world-wide 
population more than 49% in LMICs (more than 3,652 million with 50.24% 
female) with an average rate of growth of 1.93% annually and roughly 16% 
of population in HICs with a mere rate of growth of about 0.86%. Overall, 
then this study shows that though higher wealth and wellbeing within and 
between countries, it seems that the risk of mortality and incidence in 
breast cancer is continuing to growth likely associated to the dynamics of 
socioeconomic evolution of nations. 
Future efforts in this research field should provide more statistical 
evidence to substantiate the results here. Hence, to reiterate, the study here 
is exploratory in nature and there is need for much more detailed research 
to shed further theoretical and empirical light on patterns of incidence and 
mortality of breast cancer within and between countries. 
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